[Dyskeratosis congenita, a disease caused by defective telomere maintenance].
Dyskeratosis congenita (DC), also called Zinsser-Cole-Engman syndrome, is a rare, often fatal, inherited disease described for the first time at the dermatological level by Zinsser in 1906. It is a very polymorphous disease at the clinical level, with several modes of inheritance. Several clinical symptoms of the disease can appear after a latency period. These features render DC particularly difficult to diagnose. Mutations of several genes can cause DC, four of them having been identified so far. However, for a majority of patients, the affected gene has not been found. Remarkably, all identified genes (DKC1, hTERC, hTERT, and NOP10) encode components of telomerase, all required for telomere length maintenance. DC is thus a unique clinical model for the study of the roles of telomerase and telomeres. Moreover, proteins encoded by the DKC1 and NOP10 genes are also components of so-called box H/ACA RNPs required for ribosome synthesis and pre-mRNA processing. Alterations of these processes could contribute to the symptoms of DC patients carrying mutations in DKC1 or NOP10.
Hoareau-Aveilla
Coralie
C
Laboratoire de Biologie Moléculaire Eucaryote du CNRS, Université de Toulouse, UPS, 118 route de Narbonne, 31062 Toulouse cedex 09, France.
Henry
Yves
Y
Leblanc
Thierry
T
D019871:Dyskeratosis Congenita / Q000175:diagnosis / Q000235:genetics* / Q000503:physiopathology; D006801:Humans; D008957:Models, Genetic; D010641:Phenotype; D011560:Pseudouridine / Q000378:metabolism; D012313:RNA / Q000235:genetics; D019098:Telomerase / Q000235:genetics / Q000378:metabolism; D016615:Telomere / Q000235:genetics*; D014529:Uridine / Q000378:metabolism
D011560:Pseudouridine; D012313:RNA; D019098:Telomerase; D014529:Uridine